Cargando…
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
KRAS is a frequent driver in lung cancer. To identify KRAS-specific vulnerabilities in lung cancer, we performed RNAi screens in primary spheroids derived from a Kras mutant mouse lung cancer model and discovered an epigenetic regulator Ubiquitin-like containing PHD and RING finger domains 1 (UHRF1)...
Autores principales: | Kostyrko, Kaja, Román, Marta, Lee, Alex G., Simpson, David R., Dinh, Phuong T., Leung, Stanley G., Marini, Kieren D., Kelly, Marcus R., Broyde, Joshua, Califano, Andrea, Jackson, Peter K., Sweet-Cordero, E. Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322837/ https://www.ncbi.nlm.nih.gov/pubmed/37407562 http://dx.doi.org/10.1038/s41467-023-39591-2 |
Ejemplares similares
-
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
por: Valencia, Karmele, et al.
Publicado: (2020) -
UHRF1 regulation of the Keap1–Nrf2 pathway in pancreatic cancer contributes to oncogenesis
por: Abu‐Alainin, Wafa, et al.
Publicado: (2015) -
Synthetic Vulnerabilities in the KRAS Pathway
por: Roman, Marta, et al.
Publicado: (2022) -
SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development
por: Gagné-Sansfaçon, Jessica, et al.
Publicado: (2016) -
Assays for DNA double-strand break repair by microhomology-based end-joining repair mechanisms
por: Kostyrko, Kaja, et al.
Publicado: (2016)